D'Alessio, A., Lombardi, P., Stefanini, B., Blanter, J., Crowley, F., Shu, D., Yip, V., Slater, S., Pai, M., Goldin, R. D., Ward, S., Fiel, M. I., Su, Y., Baretti, M., Anders, R. A., Yarchoan, M., Hsu, C., Marron, T. U., Sharma, R., Pinato, D. J. (2025). Use of pathological response versus RECIST assessment in predicting relapse-free survival following neoadjuvant immunotherapy for hepatocellular carcinoma.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.4_suppl.633